Jean-Paul Castaigne

Directeur/Membre du Conseil chez Tranzyme Pharma, Inc. (Canada)

Profil

Jean-Paul Castaigne currently works at BioQuebec, as Director and Tranzyme Pharma, Inc. (Canada), as Director.
Dr. Castaigne also formerly worked at Angiochem, Inc., as President & Chief Executive Officer, JPC Consulting, as Chief Executive Officer, Trillium Therapeutics ULC, as Director from 2006 to 2007, Ocera Therapeutics, Inc., as Independent Director from 2011 to 2015, Asmacure Ltée, as Director, Novartis Groupe France SA, as Director-Medical, Research & Development, Allostera Pharma, Inc., as Director from 2006 to 2013, Novartis Healthcare Philippines, Inc., as President & Managing Director, Fondation Sur Les Leucodystrophies, as Director, ConjuChem, Inc., as Chief Operating & Scientific Officer, Cilag AG, as Principal, Novartis Pharmaceuticals Canada, Inc., as Vice President, Saint Jean Industries Lorraine SAS, as Vice President, Head-Global Research & Development, and Sanofi-Aventis Canada, Inc., as Principal.
Dr. Castaigne received his doctorate degree in 1975 from Université Paris 1 Panthéon-Sorbonne and Masters Business Admin degree in 1987 from École des Hautes Études Commerciales de Paris.

Postes actifs de Jean-Paul Castaigne

Sociétés	Poste	Début
Tranzyme Pharma, Inc. (Canada)	Directeur/Membre du Conseil	-
BioQuebec	Directeur/Membre du Conseil	-

Anciens postes connus de Jean-Paul Castaigne

Sociétés	Poste	Fin
OCERA THERAPEUTICS INC	Directeur/Membre du Conseil	18/06/2015
Allostera Pharma, Inc.	Directeur/Membre du Conseil	09/09/2013
TRILLIUM THERAPEUTICS	Directeur/Membre du Conseil	15/10/2007
Fondation Sur Les Leucodystrophies	Directeur/Membre du Conseil	-
Sanofi-Aventis Canada, Inc.	Corporate Officer/Principal	-